Mobile

A study for people with Type 2 Diabetes to see how safe and effective different drug combinations are for this disease. The combinations are saxagliptin and dapagliflozin added to metformin, saxaglip...

Mise à jour : Il y a 4 ans
Référence : EUCTR2012-000679-18

A study for people with Type 2 Diabetes to see how safe and effective different drug combinations are for this disease. The combinations are saxagliptin and dapagliflozin added to metformin, saxagliptin added to metformin, or dapagliflozin with metformin

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To compare the mean change from baseline in glycosylated hemoglobin (HbA1c) achieved with concurrent addition of saxagliptin and dapagliflozin to metformin versus the addition of placebo & saxagliptin to metformin & versus the addition of placebo plus dapagliflozin to metformin after 24 weeks of double-blind treatment.

Critère d'inclusion

  • Type 2 Diabetes who have Inadequate Glycemic Control on Metformin Alone

Liens